Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06670040

Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder

Sham-Controlled rTMS for Refractory Depression in Autism Spectrum Disorder

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
13 Years – 26 Years
Healthy volunteers
Not accepted

Summary

Evaluate the efficacy of accelerated theta burst stimulation (aTBS) in reducing depressive symptoms in autism spectrum disorder (ASD)

Detailed description

The overall goal of this study is to treat major depressive disorder (MDD) rapidly and effectively in individuals with autism spectrum disorder (ASD). Our central hypothesis is that accelerated theta burst stimulation (aTBS) targeting the left dorsal lateral prefrontal cortex (DLPFC) will significantly improve MDD symptoms and rate of remission compared to sham. We propose a double-blind RCT of 13-to 26-year-old individuals with ASD with MDD to test the efficacy of aTBS (n=12) versus sham (n=12) treatment. Participants will be rigorously characterized, including co-occurring conditions, any concurrent therapies, medications, social function, cognition, and sensory profile. A core battery of assessments will assess the efficacy of the intervention and maintenance of gains with respect to MDD and ASD-specific symptomology. Neural target engagement will be assessed by source-localized Electroencephalography (EEG) connectivity.

Conditions

Interventions

TypeNameDescription
PROCEDURETranscranial Magnetic StimulationAll TBS sessions will be delivered at the same site, intensity (up to 90% RMT), pattern and duration. Treatment conditions differ only in the amount of intracranial activation induced (i.e., negligible activation in sham condition). TBS sessions consist of triplet 50 Hz bursts repeated every 200 msec (5 Hz), delivered to the left DLPFC in an intermittent (2 seconds on/8 seconds off) pattern for a total of 600 pulses per session; duration of 3 minutes 9 seconds.
PROCEDURETranscranial Magnetic Stimulation ShamWe will use a robust sham technique that suitably replicates the sensory experience (auditory and peripheral activation) of active TBS with minimal intracranial activation. The Magstim Horizon™ sham coil will be utilized for treatment delivery. This sham coil is visually identical to the active coil and replicates the sounds and sensation of the magnetic stimulation. All sham treatment will be delivered at the same site, intensity (up to 90% RMT), pattern and duration. Treatment conditions differ only in the amount of intracranial activation induced (i.e., negligible activation in sham condition). TBS sessions consist of triplet 50 Hz bursts repeated every 200 msec (5 Hz), delivered to the left DLPFC in an intermittent (2 seconds on/8 seconds off) pattern for a total of 600 pulses per session; duration of 3 minutes 9 seconds

Timeline

Start date
2024-09-16
Primary completion
2026-04-30
Completion
2026-04-30
First posted
2024-11-01
Last updated
2026-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06670040. Inclusion in this directory is not an endorsement.